Liu Min, Cao Siyu, Guo Ziyi, Wu Zong, Meng Jiao, Wu Yong, Shao Yang, Li Yanli
Lab for Noncoding RNA and Cancer, School of Life Sciences, Shanghai University, Shanghai, China.
Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Front Cell Dev Biol. 2022 Nov 23;10:1044897. doi: 10.3389/fcell.2022.1044897. eCollection 2022.
Ovarian cancer (OC) is one of the female malignancies with nearly 45% 5-year survival rate. Circular RNAs (circRNAs), a kind of single-stranded non-coding RNAs, are generated from the back-splicing of cellular housekeeping noncoding RNAs and precursor messenger RNAs. Recent studies revealed that circRNAs have different biological function, including sponging miRNAs, encoding micropeptides, regulating stability of cytoplasmic mRNAs, affecting transcription and splicing, interacting with DNA, RNA and proteins. Due to their stability, circRNAs have the potential of acting as biomarkers and treatment targets. In this review, we briefly illustrate the biogenesis mechanism and biological function of circRNAs in OC, and make a perspective of circRNAs drug targeting immune responses and signaling pathways in OC. This article can provide a systematic view into the current situation and future of circRNAs in OC.
卵巢癌(OC)是女性恶性肿瘤之一,其5年生存率近45%。环状RNA(circRNAs)是一类单链非编码RNA,由细胞管家非编码RNA和前体信使RNA的反向剪接产生。最近的研究表明,circRNAs具有不同的生物学功能,包括充当微小RNA(miRNAs)的海绵、编码微肽、调节细胞质mRNA的稳定性、影响转录和剪接、与DNA、RNA和蛋白质相互作用。由于其稳定性,circRNAs有潜力作为生物标志物和治疗靶点。在本综述中,我们简要阐述了circRNAs在OC中的生物发生机制和生物学功能,并对circRNAs靶向OC免疫反应和信号通路的药物进行了展望。本文可以提供一个关于circRNAs在OC中的现状和未来的系统观点。